Figure 2.

MR-derived, individual, relative tumor volumes over time after 177Lu-octreotate therapy (n = 21). In ~50% of the tumors, the volume is transiently reduced after treatment, whereas growth rate is reduced in the other half. After day 8, increasing volume is observed in most tumors again.